Overdose antidote Narcan to be sold over-the-counter, FDA says

The U.S. Food and Drug Administration on Wednesday approved selling the overdose antidote drug naloxone over-the-counter, putting it on course to be the first opioid treatment drug sold without a prescription. The spray version of the drug, sold under the name Narcan, will be available for sale by late summer, according to the drug’s manufacturer, Emergent BioSolutions. Experts praised the move to make naloxone more accessible as the national opioid crisis continues. But they are concerned the drug could be too expensive without a prescription. “This is a great step...